ERMA Report on Equine Influenza Available

ERMA New Zealand's Evaluation and Review Report on the application to import
and use, under controlled conditions, a live genetically modified virus
vaccine to protect horses against Equine Influenza has been published and is
available on the organisation's website, www.ermanz.govt.nz .

The application has been made by the New Zealand Racing Board and New Zealand
Equine Health Association Incorporated.

The Evaluation and Review Report is a source of information to the
Environmental Risk Management Authority.

It describes the organisms which are the subject of the conditional release
application, and analyses the risks, costs and benefits of the genetically
modified organisms contained in the vaccines (Proteqflu and Proteqflu Te).

It also proposes conditions, or controls, that could be placed on the vaccine
if the application were to be approved by the Authority.

The report forms part of the information the Authority will consider in
making its decision. It will also consider information received from the
applicant and from the 29 people and organisations that made submissions on
the application.

The Authority will hear additional information from the applicant and eight
submitters who requested to be heard at a public hearing scheduled to be held
on Tuesday 7 October 2008 in Wellington.

The Authority's decision is usually available within 30 working days of a
hearing.

ERMA New Zealand's responsibility is limited to the GMO component of the
vaccine. Approval to use the vaccine must also be obtained from the NZ Food
Safety Authority's Agricultural Compounds and Veterinary Medicines Group.